SARS-CoV-2 RSS
Novavax, the recombinant nanoparticle Covid-19 vaccine.
Novavax is a new recombinant nanoparticle vaccine of coronavirus 2 (SARS-CoV-2) with an adjuvant, based on saponins extracted from the bark of Quillaja saponaria Molina that improves immune responses and allows for a reduction in the vaccine dose.
New monoclonal antibody designed to neutralize SARS-CoV-2
Monoclonal antibody therapy is a type of drug that can be used both to prevent SARS-CoV-2 infection and to treat it once the disease has developed.
Tags
- All
- ADN
- Alternativa
- Anticuerpo monoclonal
- Anticuerpos
- ARN
- beneficios
- Biorreactores
- Cambios sociales
- Células plas
- Células plasmáticas
- Coronavirus
- covid
- COVID-19
- Educación
- espíritu
- Genes
- Genoma humano
- health
- healthcare
- Hongo negro
- Inmunidad
- Médula ósea
- Método CRISPR/Cas9
- Mucorales
- Mucormicosis
- Mujeres Premio Nobel
- Nanopartículas
- Nicotiana benthamiana
- Nuevas profesiones
- Pandemia
- Premio Princesa de Asturias
- Quillaja saponaria
- Replicación
- Resiliencia
- Ribosomas
- Salud
- SARS-CoV-2
- School
- Tecnologías
- Telemedicina
- Trabajo en casa
- Vacuna
- Vacuna de origen vegetal
- virus
- Zoonosis